CPB vs MLYS · P/E 12, rev $10.25B vs $2.17B cap
Campbell’s Co (CPB) versus Mineralys Therapeutics, Inc. Common Stock (MLYS) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Mineralys Therapeutics, Inc. Common Stock (MLYS) is a biotechnology company listed on US.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
MLYS does not have a complete income-statement cache yet.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. MLYS currently screens at market cap $2.17B.
Not investment advice. Open the CPB and MLYS stock pages for the full models.
Not investment advice.